Pasiniazid
-
Pasiniazid
structure -
-
CAS No:
2066-89-9
-
Formula:
C7H7NO3.C6H7N3O
-
Chemical Name:
Pasiniazid
-
Synonyms:
4-Pyridinecarboxylic acid,hydrazide,compd. with 4-amino-2-hydroxybenzoate (1:1);Isonicotinic acid hydrazide,mono(4-aminosalicylate);4-Pyridinecarboxylic acid,hydrazide,mono(4-amino-2-hydroxybenzoate);Salicylic acid,4-amino-,compd. with isonicotinic acid hydrazide;Salicylic acid,4-amino-,compd. with isoniazid;Salicylic acid,4-amino-,compd. with isonicotinic acid hydrazide (1:1);Benzoic acid,4-amino-2-hydroxy-,compd. with 4-pyridinecarboxylic acid hydrazide (1:1);p-Aminosalicylic acid isonicotinyl hydrazide;Dipasic;Fintozid;Isoniazid 4-aminosalicylate;Pasiniazide;Pasiniazid;Isonicotinic acid hydrazide p-aminosalicylate;Nidrapas;Paraniazide;Parasal INH;Pascidaber;Pashain;Pas-Hidracida;GEWO 399;6190-85-8
-
Categories:
Active Pharmaceutical Ingredients > Synthetic Anti-infective Drugs
-
CAS No:
Description
Pasiniazid is an anti-TB and anti-leprosy drug, used to treat various types of TB and leprosy.
Safety Information
NONH for all modes of transport
3
22-36/37/38
26-36/37
Xn,Xi
P261-P305 + P351 + P338
H302-H315-H319-H335
|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 38 companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Computed Properties
Molecular Weight:290.27
Hydrogen Bond Donor Count:5
Hydrogen Bond Acceptor Count:7
Rotatable Bond Count:2
Exact Mass:290.10150494
Monoisotopic Mass:290.10150494
Topological Polar Surface Area:152
Heavy Atom Count:21
Complexity:280
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes
Drug Function and Efficacy
This product is a chemical synthesis of isoniazid (INH) and para-aminosalicylic acid (PAS). INH is mainly effective against mycobacteria in the growth and reproduction period, and may inhibit the synthesis of mycolic acid (myolic acid) of sensitive bacteria and cause cell wall rupture. PAS delays and blocks the acetylation process of INH in the body, enhances the bactericidal effect of the drug and delays the development of bacterial resistance. Clinically confirmed, in combination with other anti-tuberculosis drugs, the anti-tuberculosis efficacy of this product is significantly better than INH, and the incidence of adverse reactions is significantly lower than INH. Animal experiments show that the anti-tuberculosis efficacy of this product is about 5 times that of INH.
Registered Holders
-
Chongqing Shengkai Pharmaceutical Co., Ltd.
Active
China
-
Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
Active
China
-
Guizhou Shenqi Pharmaceutical Co., Ltd.
Active
China
Learn More Other Chemicals
-
Phenoxyethanol
122-99-6
-
4-Aminosalicylic acid
65-49-6
-
1,3-Propanediol, 2-[(acetyloxy)methoxy]-, 1,3-diacetate
86357-13-3
-
Ethanol, 2-[(acetyloxy)methoxy]-, 1-acetate Formula
59278-00-1
-
Maraviroc Formula
376348-65-1
-
Lopinavir Formula
192725-17-0
-
Luliconazole Structure
187164-19-8
-
Methenamine hippurate Structure
5714-73-8
-
What is Nifuratel
4936-47-4
-
What is Flumequine
42835-25-6